| Prelude Fertility | 71.7 | 3 | 1 |
| Pacific Fertility Center Los Angeles (PFCLA) | 71.7 | 3 | 1 |
| Colorado Center for Reproductive Medicine | 61.0 | 2 | 1 |
| Sher Fertility | 61.0 | 2 | 1 |
| Michigan Reproductive Medicine | 61.0 | 2 | 1 |
| Mayo Clinic | 60.0 | 4 | 0 |
| Alliant | 60.0 | 4 | 0 |
| National Institute for Occupational Safety and Health | 51.7 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 51.7 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 51.7 | 3 | 0 |
| Pacific Fertility Center | 51.7 | 3 | 0 |
| Office of Readiness and Response | 51.7 | 3 | 0 |
| American Society for Reproductive Medicine | 45.8 | 1 | 1 |
| Single Mothers by Choice | 45.8 | 1 | 1 |
| Seattle Reproductive Medicine | 45.8 | 1 | 1 |
| Reproductive Medicine Associates of New York | 45.8 | 1 | 1 |
| Reproductive Medicine Associates of New Jersey | 45.8 | 1 | 1 |
| Reproductive Medicine Institute | 45.8 | 1 | 1 |
| Epi Info | 41.0 | 2 | 0 |
| Preventing Chronic Disease | 41.0 | 2 | 0 |
| National Survey of Family Growth | 41.0 | 2 | 0 |
| National Vital Statistics System | 41.0 | 2 | 0 |
| NIOSH Power Tools Database | 41.0 | 2 | 0 |
| Oregon Graduate Center | 41.0 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 41.0 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 41.0 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 41.0 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 41.0 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 41.0 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 41.0 | 2 | 0 |
| NCHS data brief | 41.0 | 2 | 0 |
| MMWR supplements | 41.0 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 41.0 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 41.0 | 2 | 0 |
| San Diego Fertility Center | 41.0 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 41.0 | 2 | 0 |
| Shady Grove Fertility Center | 41.0 | 2 | 0 |
| assisted reproductive technology | 40.0 | 0 | 3 |
| fertility clinic | 40.0 | 0 | 3 |
| Fertility and Sterility | 40.0 | 0 | 3 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 40.0 | 0 | 3 |
| Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination | 40.0 | 0 | 3 |
| Fertility clinic, egg donation agency, and sperm bank policies | 40.0 | 0 | 3 |
| Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues | 40.0 | 0 | 3 |
| Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterin | 40.0 | 0 | 3 |
| The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer | 40.0 | 0 | 3 |
| Three pro-nuclei (3PN) incidence factors and clinical outcomes: a retrospective study from the fresh embryo transfer of in vitro fertilization with donor sperm (IVF-D) | 40.0 | 0 | 3 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 40.0 | 0 | 3 |
| The promise of in vitro maturation in assisted reproduction and fertility preservation. | 40.0 | 0 | 3 |
| Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders | 40.0 | 0 | 3 |
| Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation | 40.0 | 0 | 3 |
| Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET). | 40.0 | 0 | 3 |
| In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. | 40.0 | 0 | 3 |
| Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study | 40.0 | 0 | 3 |
| Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer | 40.0 | 0 | 3 |
| Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility. | 40.0 | 0 | 3 |
| Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles | 40.0 | 0 | 3 |
| Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012 | 40.0 | 0 | 3 |
| Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure | 40.0 | 0 | 3 |
| Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer | 40.0 | 0 | 3 |
| Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients | 40.0 | 0 | 3 |
| Ovarian stimulation in intrauterine insemination with donor sperm: a randomized study comparing clomiphene citrate in fixed protocol versus highly purified urinary FSH. | 40.0 | 0 | 3 |
| Intrauterine insemination with frozen donor sperm. Pregnancy outcome in relation to age and ovarian stimulation regime | 40.0 | 0 | 3 |
| Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer | 40.0 | 0 | 3 |
| Personal experience with ovarian stimulation in an in vitro fertilization and embryo transfer program | 40.0 | 0 | 3 |
| Optimal treatment for poor responders to ovarian stimulation: does in vitro insemination offer any advantages to intrauterine insemination? | 40.0 | 0 | 3 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 40.0 | 0 | 3 |
| Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study. | 40.0 | 0 | 3 |
| Comparison of clinical outcome of mild-stimulation and conventional ovarian stimulation in in vitro fertilization-embryo transfer (IVF-ET) | 40.0 | 0 | 3 |
| Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine | 40.0 | 0 | 3 |
| First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient | 40.0 | 0 | 3 |
| Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation | 40.0 | 0 | 3 |
| Ovarian stimulation, egg aspiration, in vitro fertilization and embryo transfer in the baboon (Papio anubis): a pilot project at the Institute of Primate Research, Nairobi, Kenya | 40.0 | 0 | 3 |
| Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation | 40.0 | 0 | 3 |
| Reprotoxicity of intrauterine insemination and in vitro fertilization-embryo transfer disposables and products: a 4-year survey | 40.0 | 0 | 3 |
| Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles | 40.0 | 0 | 3 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 40.0 | 0 | 3 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 40.0 | 0 | 3 |
| Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction? | 40.0 | 0 | 3 |
| CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer | 40.0 | 0 | 3 |
| Further observations on serial serum immunoreactive inhibin levels in the luteal phase and early gestation after ovarian stimulation for in vitro fertilization and embryo transfer | 40.0 | 0 | 3 |
| Comparison of four different ovarian stimulation protocols in an in vitro fertilisation & embryo transfer programme | 40.0 | 0 | 3 |
| Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication | 40.0 | 0 | 3 |
| Factors influencing the success rate of human embryo freezing in an in vitro fertilization and embryo transfer program. | 40.0 | 0 | 3 |
| Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? | 40.0 | 0 | 3 |
| Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART) | 40.0 | 0 | 3 |
| Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment | 40.0 | 0 | 3 |
| A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment | 40.0 | 0 | 3 |
| Egg Freezing Pilot Study | 40.0 | 0 | 3 |
| Fertility Preservation by Ovarian and Oocyte Cryopreservation | 40.0 | 0 | 3 |
| Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial. | 40.0 | 0 | 3 |
| Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment | 40.0 | 0 | 3 |
| NATural Ovarian Stimulation | 40.0 | 0 | 3 |
| Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer | 40.0 | 0 | 3 |
| Clomiphene-HMG ovarian stimulation in human in vitro fertilization and embryo transfer | 40.0 | 0 | 3 |
| In vitro fertilization and other assisted reproduction. Vth World Congress on In Vitro Fertilization and Embryo Transfer. Norfolk, Virginia, April 5-10, 1987. Proceedings | 40.0 | 0 | 3 |
| An analysis of the LH profile in relation to ovarian stimulation regimes and embryo transfer rates in an in vitro fertilisation programme | 40.0 | 0 | 3 |
| The effect of periovarian adhesions on follicular development in patients undergoing ovarian stimulation for in vitro fertilization-embryo transfer | 40.0 | 0 | 3 |
| The results of in vitro fertilization-embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination | 40.0 | 0 | 3 |
| A comparison of early gestational age markers in viable twin pregnancies resulting from in vitro fertilization-embryo transfer versus spontaneous conception with ovarian stimulation | 40.0 | 0 | 3 |
| A case of forearm amputation after ovarian stimulation for in vitro fertilization-embryo transfer | 40.0 | 0 | 3 |
| In vitro fertilization laboratory. Clinical features of assisted reproduction techniques. Male infertility treatment in a reproduction medicine centre | 40.0 | 0 | 3 |
| Current Preventive Strategies for Preovulatory Progesterone Elevation During Ovarian Stimulation for In Vitro Fertilization | 40.0 | 0 | 3 |
| Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study | 40.0 | 0 | 3 |
| Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic | 40.0 | 0 | 3 |
| Curative effect of assisted reproduction technology by Traditional Chinese Medicine multi-channel interventional therapy on 95 cases of in vitro fertilization and embryo transfer failure | 40.0 | 0 | 3 |
| The effects of intrauterine insemination and single embryo transfer or modified natural cycle in vitro fertilization on offspring's health-Follow-up of a randomized clinical trial | 40.0 | 0 | 3 |
| Analysis of embryo quality with luteal phase ovarian stimulation after failed in vitro fertilization-embryo transfer with long or ultra-long protocol | 40.0 | 0 | 3 |
| Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible | 40.0 | 0 | 3 |
| How does freeze-all strategy compare with conventional in vitro fertilization and fresh embryo transfer during assisted reproduction? | 40.0 | 0 | 3 |
| GYN-FIV a.s. | 40.0 | 0 | 3 |
| Robert Edwards | 31.7 | 0 | 2 |
| sperm bank | 31.7 | 0 | 2 |
| egg donation | 31.7 | 0 | 2 |
| Vitrification (ovocytes) | 31.7 | 0 | 2 |
| third-party reproduction | 31.7 | 0 | 2 |
| Journal of Assisted Reproduction and Genetics | 31.7 | 0 | 2 |
| Reproductive Medicine and Biology | 31.7 | 0 | 2 |
| single mother | 31.7 | 0 | 2 |
| Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies | 31.7 | 0 | 2 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 31.7 | 0 | 2 |
| In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction | 31.7 | 0 | 2 |
| Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization | 31.7 | 0 | 2 |
| Clomiphene citrate for controlled ovarian stimulation in women undergoing in vitro fertilization | 31.7 | 0 | 2 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation | 31.7 | 0 | 2 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 31.7 | 0 | 2 |
| In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction | 31.7 | 0 | 2 |
| In vitro maturation in sub fertile patients with polycystic ovarian syndrome undergoing assisted reproduction | 31.7 | 0 | 2 |
| Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility | 31.7 | 0 | 2 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles | 31.7 | 0 | 2 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 31.7 | 0 | 2 |
| Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility | 31.7 | 0 | 2 |
| Recombinant versus urinary derived gonadotrophins for ovarian stimulation in in vitro fertilisation and intra-cytoplasmic sperm injection cycles | 31.7 | 0 | 2 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation | 31.7 | 0 | 2 |
| Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination | 31.7 | 0 | 2 |
| First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy | 31.7 | 0 | 2 |
| Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization | 31.7 | 0 | 2 |
| The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment | 31.7 | 0 | 2 |
| Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer | 31.7 | 0 | 2 |
| The prognostic profile of subfertile couples and treatment outcome after expectant management, intrauterine insemination and in vitro fertilisation: a study protocol for the meta-analysis of individual patient data | 31.7 | 0 | 2 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 31.7 | 0 | 2 |
| Effectiveness of GnRH Antagonist in the Management of Subfertile Couples Undergoing Controlled Ovarian Stimulation and Intrauterine Insemination: A Meta-Analysis | 31.7 | 0 | 2 |
| Journal of in vitro fertilization and embryo transfer : IVF | 31.7 | 0 | 2 |
| Journal of fertilization. In vitro IVF worldwide reproductive medicine genetics & stem cell biology | 31.7 | 0 | 2 |
| Abdominal ectopic pregnancy after in vitro fertilization and single embryo transfer: a case report and systematic review | 31.7 | 0 | 2 |
| Debating Elective Single Embryo Transfer after in vitro Fertilization: A Plea for a Context-Sensitive Approach | 31.7 | 0 | 2 |
| Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer | 31.7 | 0 | 2 |
| Hysteroscopic cervical canal shaving: a new therapy for cervical stenosis before embryo transfer in patients undergoing in vitro fertilization | 31.7 | 0 | 2 |
| Effects of co-administration of growth hormone(GH) and aspirin to women during in vitro fertilization and embryo transfer (IVF-ET) cycles | 31.7 | 0 | 2 |
| Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients | 31.7 | 0 | 2 |
| In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe | 31.7 | 0 | 2 |
| Similarin vitromaturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients | 31.7 | 0 | 2 |
| What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation? | 31.7 | 0 | 2 |
| Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis | 31.7 | 0 | 2 |
| Serum progestagen-associated endometrial protein (PEP) levels in conception versus nonconception cycles following in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Q28344605 | 31.7 | 0 | 2 |
| Urinary bisphenol A concentrations and association within vitrofertilization outcomes among women from a fertility clinic | 31.7 | 0 | 2 |
| Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic | 31.7 | 0 | 2 |
| Dietary folate intake and modification of the association of urinary bisphenol A concentrations with in vitro fertilization outcomes among women from a fertility clinic | 31.7 | 0 | 2 |
| Hair mercury concentrations and in vitro fertilization (IVF) outcomes among women from a fertility clinic | 31.7 | 0 | 2 |
| Useful Predictors of Ovarian Stimulation Response in Women Undergoing in vitro Fertilization | 31.7 | 0 | 2 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. | 31.7 | 0 | 2 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation. | 31.7 | 0 | 2 |
| Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics | 31.7 | 0 | 2 |
| Predictors of participant retention in infertility treatment trials | 31.7 | 0 | 2 |
| Randomized Trial of Harp Therapy During In Vitro Fertilization–Embryo Transfer | 31.7 | 0 | 2 |
| First-trimester diagnosis and management of Cesarean scar pregnancies after in vitro fertilization-embryo transfer: a retrospective clinical analysis of 12 cases | 31.7 | 0 | 2 |
| Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization. | 31.7 | 0 | 2 |
| Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial | 31.7 | 0 | 2 |
| In vitro fertilization - analysis of data in Czech National Assisted Reproduction Register from years 2007-2011 | 31.7 | 0 | 2 |
| Obligatory versus elective single embryo transfer in in vitro fertilization. A population-based analysis of data from the U.K. Human Fertilisation and Embryology Authority | 31.7 | 0 | 2 |
| Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion | 31.7 | 0 | 2 |
| Could induced apoptosis of human granulosa cells predict in vitro fertilization-embryo transfer outcome? A preliminary study of 25 women. | 31.7 | 0 | 2 |
| Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix | 31.7 | 0 | 2 |
| Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome | 31.7 | 0 | 2 |
| Risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes | 31.7 | 0 | 2 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion | 31.7 | 0 | 2 |
| Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial | 31.7 | 0 | 2 |
| Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique | 31.7 | 0 | 2 |
| The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. | 31.7 | 0 | 2 |
| Analysis of the pregnancy outcomes of 13 723 tubes of sperm specimens from the sperm bank | 31.7 | 0 | 2 |
| Artificial insemination and use of a sperm bank at the fertility clinic of the C.H.U.L. (Centre hospitalier de l'université Larval) | 31.7 | 0 | 2 |
| Primate Follicular Development and Oocyte Maturation In Vitro | 31.7 | 0 | 2 |
| Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial | 31.7 | 0 | 2 |
| The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis | 31.7 | 0 | 2 |
| Elective single embryo transfer following in vitro fertilization | 31.7 | 0 | 2 |
| Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options | 31.7 | 0 | 2 |
| Efficiency of metaphase II oocytes following minimal/mild ovarian stimulation in vitro fertilization | 31.7 | 0 | 2 |
| Analysis of oocyte cryopreservation in assisted reproduction: the Italian National Register data from 2005 to 2007 | 31.7 | 0 | 2 |
| Impacts of Anti-dsDNA Antibody on In Vitro Fertilization-Embryo Transfer and Frozen-Thawed Embryo Transfer. | 31.7 | 0 | 2 |
| The efficacy and adverse effects of in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles | 31.7 | 0 | 2 |
| Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study | 31.7 | 0 | 2 |
| Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study | 31.7 | 0 | 2 |
| Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction. | 31.7 | 0 | 2 |
| The Photosensitivity Localized in a Vitiliginous Lesion Was Associated with the Intramuscular Injections of Synthetic Progesterone during an In Vitro Fertilization-embryo Transfer | 31.7 | 0 | 2 |
| Follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cycles | 31.7 | 0 | 2 |
| Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates | 31.7 | 0 | 2 |
| Comparison of clinical outcomes between fresh embryo transfers and frozen-thawed embryo transfers | 31.7 | 0 | 2 |
| Does prayer influence the success of in vitro fertilization-embryo transfer? Report of a masked, randomized trial. | 31.7 | 0 | 2 |
| In vitro manipulation of nonhuman primate gametes for embryo production and embryo transfer | 31.7 | 0 | 2 |
| Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial | 31.7 | 0 | 2 |
| Does the Ovarian Stimulation Phase Length Predict In vitro Fertilization Outcomes? | 31.7 | 0 | 2 |
| Evaluation of clinical factors influencing pregnancy rate in frozen embryo transfer | 31.7 | 0 | 2 |
| The importance of the cleavage stage morphology evaluation for blastocyst transfer in patients with good prognosis | 31.7 | 0 | 2 |
| Effect of male hepatitis B virus infection on outcomes of in vitro fertilization and embryo transfer treatment: insights from couples undergoing oocyte donation | 31.7 | 0 | 2 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles. | 31.7 | 0 | 2 |
| Predictive value of plasma human chorionic gonadotrophin beta subunit in diagnosing ectopic pregnancy after in vitro fertilisation and embryo transfer | 31.7 | 0 | 2 |
| Impact of short-term preconceptional exposure to particulate air pollution on treatment outcome in couples undergoing in vitro fertilization and embryo transfer (IVF/ET) | 31.7 | 0 | 2 |
| How the FMR1 gene became relevant to female fertility and reproductive medicine | 31.7 | 0 | 2 |
| Single-donor and double-donor sperm intrauterine insemination cycles: does double intrauterine insemination increase clinical pregnancy rates? | 31.7 | 0 | 2 |
| Fertility preservation outcomes may differ by cancer diagnosis | 31.7 | 0 | 2 |
| Term delivery following pyometra after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| In vitro technologies related to pig embryo transfer. | 31.7 | 0 | 2 |
| Eight-hydroxy-2'-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program | 31.7 | 0 | 2 |
| Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer | 31.7 | 0 | 2 |
| Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature | 31.7 | 0 | 2 |
| Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. | 31.7 | 0 | 2 |
| Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes | 31.7 | 0 | 2 |
| The breadth of in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Delivery after intrauterine embryo transfer obtained by fertilization and oocyte culture in vitro | 31.7 | 0 | 2 |
| Efficacy of the local endometrial injury in patients who had previous failed IVF-ICSI outcome | 31.7 | 0 | 2 |
| Cornual heterotopic pregnancy and cornual resection after in vitro fertilization/embryo transfer. A report of two cases | 31.7 | 0 | 2 |
| Parameters that predict success for natural cycle in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration | 31.7 | 0 | 2 |
| Use of third generation gonadotropin-releasing hormone antagonists in in vitro fertilization-embryo transfer: a review | 31.7 | 0 | 2 |
| Efficacy and safety of long-acting GnRH agonists in in vitro fertilization and embryo transfer. | 31.7 | 0 | 2 |
| Gene expression and DNA-methylation of bovine pretransfer endometrium depending on its receptivity after in vitro-produced embryo transfer | 31.7 | 0 | 2 |
| Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation | 31.7 | 0 | 2 |
| Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| Age, body mass index, and number of previous trials: are they prognosticators of intra-uterine-insemination for infertility treatment? | 31.7 | 0 | 2 |
| Marked improvement in clinical pregnancy rates following in vitro fertilization-embryo transfer seen when transfer technique and catheter were changed. | 31.7 | 0 | 2 |
| Impaired glucose metabolism in response to high fat diet in female mice conceived by in vitro fertilization (IVF) or ovarian stimulation alone | 31.7 | 0 | 2 |
| Live birth sex ratio after in vitro fertilization and embryo transfer in China--an analysis of 121,247 babies from 18 centers | 31.7 | 0 | 2 |
| Effect of glucose concentration during in vitro culture of mouse embryos on development to blastocyst, success of embryo transfer, and litter sex ratio | 31.7 | 0 | 2 |
| Assisted reproduction and reproductive rights: the case of in vitro fertilization | 31.7 | 0 | 2 |
| Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction | 31.7 | 0 | 2 |
| Successful in vitro fertilization with anonymous donor oocytes in a patient with recurrent massive hemoperitoneum following spontaneous and induced ovulation | 31.7 | 0 | 2 |
| Reproductive medicine 2014: the year in review | 31.7 | 0 | 2 |
| Does IVF cleavage stage embryo quality affect pregnancy complications and neonatal outcomes in singleton gestations after double embryo transfers? | 31.7 | 0 | 2 |
| Concurrent ovarian and ipsilateral tubal ectopic pregnancies after a double embryo transfer: a case report | 31.7 | 0 | 2 |
| Oocyte Cryopreservation for Fertility Preservation in Postpubertal Female Children at Risk for Premature Ovarian Failure Due to Accelerated Follicle Loss in Turner Syndrome or Cancer Treatments | 31.7 | 0 | 2 |
| Deep intrauterine insemination and embryo transfer in pigs. | 31.7 | 0 | 2 |
| In vitro fertilisation and embryo transfer for bilateral salpingectomies results in a ruptured ovarian ectopic pregnancy due to a tubal stump fistula: a case report and review of the literature | 31.7 | 0 | 2 |
| Interstitial pregnancy after in vitro fertilization and embryo transfer following bilateral salpingectomy: report of two cases and literature review | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion | 31.7 | 0 | 2 |
| Do polymorphic variants of chromosomes affect the outcome of in vitro fertilization and embryo transfer treatment? | 31.7 | 0 | 2 |
| Treatment-independent pregnancy after in vitro fertilization and embryo transfer trial | 31.7 | 0 | 2 |
| Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway | 31.7 | 0 | 2 |
| Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminished ovarian reserve | 31.7 | 0 | 2 |
| Bilateral ovarian pregnancy after intrauterine insemination and controlled ovarian stimulation | 31.7 | 0 | 2 |
| The Effect of Single Embryo Transfer on Perinatal Outcomes in Japan | 31.7 | 0 | 2 |
| Uncomplicated pregnancy and normal singleton delivery after surgical excision of heterotopic (cornual) pregnancy following in vitro fertilization/embryo transfer | 31.7 | 0 | 2 |
| Intrauterine insemination with or without mild ovarian stimulation in couples with male subfertility due to oligo/astheno- and/or teratozoospermia or antisperm antibodies: a prospective cross-over trial. | 31.7 | 0 | 2 |
| Morphokinetic analysis of cleavage stage embryos and its relationship to aneuploidy in a retrospective time-lapse imaging study | 31.7 | 0 | 2 |
| The clinical outcomes of day 3 4-cell embryos after extended in vitro culture | 31.7 | 0 | 2 |
| Two interesting cases of ovarian pregnancy after in vitro fertilization-embryo transfer and its successful laparoscopic management | 31.7 | 0 | 2 |
| Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 31.7 | 0 | 2 |
| High-response intrauterine insemination cycles converted to low-cost in vitro fertilization | 31.7 | 0 | 2 |
| In vitro production of bovine embryos and their application for embryo transfer | 31.7 | 0 | 2 |
| Live birth after in vitro fertilization and single embryo transfer in a kidney transplant patient: a case report and review of the literature | 31.7 | 0 | 2 |
| Thirteen -weeks ovarian pregnancy following in vitro fertilization for primary infertility treatment: A case report | 31.7 | 0 | 2 |
| Ovarian stimulation in patients with breast cancer | 31.7 | 0 | 2 |
| Effects of Liuwei Dihuang Granule ([symbols; see text]) on the outcomes of in vitro fertilization pre-embryo transfer in infertility women with Kidney-yin deficiency syndrome and the proteome expressions in the follicular fluid. | 31.7 | 0 | 2 |
| Effect of single embryo transfer on the risk of preterm birth associated with in vitro fertilization | 31.7 | 0 | 2 |
| Secrecy, disclosure and everything in-between: decisions of parents of children conceived by donor insemination, egg donation and surrogacy | 31.7 | 0 | 2 |
| Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization | 31.7 | 0 | 2 |
| The case for initial treatment with intrauterine insemination as opposed to in vitro fertilization for idiopathic infertility | 31.7 | 0 | 2 |
| Hospital mental health admissions in women after unsuccessful infertility treatment and in vitro fertilization: an Australian population-based cohort study | 31.7 | 0 | 2 |
| Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization | 31.7 | 0 | 2 |
| Intrafollicular cortisol levels inversely correlate with cumulus cell lipid content as a possible energy source during oocyte meiotic resumption in women undergoing ovarian stimulation for in vitro fertilization | 31.7 | 0 | 2 |
| Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience | 31.7 | 0 | 2 |
| Children conceived by in vitro fertilisation after fresh embryo transfer | 31.7 | 0 | 2 |
| Normal epigenetic inheritance in mice conceived by in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Successful Delivery Following Staphylococcus aureus Bacteremia after In Vitro Fertilization and Embryo Transfer | 31.7 | 0 | 2 |
| Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort | 31.7 | 0 | 2 |
| A Case of Pregnancy Complicated by the Development of a Tubo-ovarian Abscess Following In Vitro Fertilization and Embryo Transfer | 31.7 | 0 | 2 |
| Does surgical management of endometriosis within 6 months of an in vitro fertilization-embryo transfer cycle improve outcome? | 31.7 | 0 | 2 |
| Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: Case report | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer outcomes in relation to myometrial thickness. | 31.7 | 0 | 2 |
| Choice of ovarian stimulation regimens in assisted reproduction: finding the thread in the gonadotropin maze | 31.7 | 0 | 2 |
| Laparoscopic excision of ovarian endometrioma does not exert a qualitative effect on ovarian function: insights from in vitro fertilization and single embryo transfer cycles | 31.7 | 0 | 2 |
| Noninvasive Digital Detection of Fetal DNA in Plasma of 4-Week-Pregnant Women following In Vitro Fertilization and Embryo Transfer | 31.7 | 0 | 2 |
| Ovarian stimulation for emergency fertility preservation in cancer patients: A case series study | 31.7 | 0 | 2 |
| Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro | 31.7 | 0 | 2 |
| Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing | 31.7 | 0 | 2 |
| Comparison of obstetric outcomes in twin pregnancies after in vitro fertilization, ovarian stimulation and spontaneous conception | 31.7 | 0 | 2 |
| Intrauterine insemination: a UK survey on the adherence to NICE clinical guidelines by fertility clinics | 31.7 | 0 | 2 |
| Clinical analysis of spontaneous pregnancy reduction in the patients with multiple pregnancies undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 31.7 | 0 | 2 |
| Relationship between Antithyroid Antibody and Pregnancy Outcome following in Vitro Fertilization and Embryo Transfer | 31.7 | 0 | 2 |
| Optimal timing for elective egg freezing | 31.7 | 0 | 2 |
| Serum estradiol/progesterone ratio on day of embryo transfer may predict reproductive outcome following controlled ovarian hyperstimulation and in vitro fertilization | 31.7 | 0 | 2 |
| The dynamics of the vaginal microbiome during infertility therapy with in vitro fertilization-embryo transfer. | 31.7 | 0 | 2 |
| Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for in vitro fertilization: a meta-analysis | 31.7 | 0 | 2 |
| Does obesity have detrimental effects on IVF treatment outcomes? | 31.7 | 0 | 2 |
| Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function | 31.7 | 0 | 2 |
| Impact of different controlled ovarian stimulation protocols on the physical and psychological burdens in women undergoing in vitro fertilization/intra cytoplasmic sperm injection | 31.7 | 0 | 2 |
| In vitro fertilization in humans and embryo transfer | 31.7 | 0 | 2 |
| Miliary tuberculosis after in vitro fertilization and embryo transplantation | 31.7 | 0 | 2 |
| Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: is it safe? | 31.7 | 0 | 2 |
| Patients with polycystic ovary syndrome have successful embryo arrest | 31.7 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality | 31.7 | 0 | 2 |
| Ovarian stimulation for in vitro fertilization in patients with endometriosis | 31.7 | 0 | 2 |
| Population pharmacokinetic modelling of Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF) in healthy postmenopausal women and in infertile patients undergoing in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Uterine abscess after ultrasound-guided ovum retrieval in an in vitro fertilization-embryo transfer program: case report and review of the literature | 31.7 | 0 | 2 |
| Single or multiple embryo transfer following in vitro fertilisation for improved neonatal outcome: a systematic review of the literature | 31.7 | 0 | 2 |
| Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer | 31.7 | 0 | 2 |
| Heterotopic pregnancy after in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Salpingectomy for hydrosalpinx prior to in vitro fertilization | 31.7 | 0 | 2 |
| The role of assisted hatching in in vitro fertilization: A review of the literature | 31.7 | 0 | 2 |
| Luteal phase ovarian stimulation following oocyte retrieval: is it helpful for poor responders? | 31.7 | 0 | 2 |
| Ovarian tissue and oocyte cryopreservation | 31.7 | 0 | 2 |
| Clinical application of sperm-oocyte interaction tests in in vitro fertilization--embryo transfer and intracytoplasmic sperm injection programs | 31.7 | 0 | 2 |
| Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients | 31.7 | 0 | 2 |
| The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal? | 31.7 | 0 | 2 |
| Increased risk of preterm birth in singleton pregnancies resulting from in vitro fertilization-embryo transfer or gamete intrafallopian transfer: a meta-analysis | 31.7 | 0 | 2 |
| The Maternal Cytokine and Chemokine Profile of Naturally Conceived Gestations Is Mainly Preserved duringIn VitroFertilization and Egg Donation Pregnancies | 31.7 | 0 | 2 |
| Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation | 31.7 | 0 | 2 |
| Gonadotrophin ovarian stimulation and intrauterine insemination for unexplained infertility | 31.7 | 0 | 2 |
| Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Therapeutic maturation of endometrium in in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| ICSI treatment of severe male infertility can achieve prospective embryo quality compared with IVF of fertile donor sperm on sibling oocytes | 31.7 | 0 | 2 |
| In vivo and in vitro decondensation of human sperm and assisted reproduction technologies | 31.7 | 0 | 2 |
| Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort | 31.7 | 0 | 2 |
| Phospholipase C-zeta deficiency as a cause for repetitive oocyte fertilization failure during ovarian stimulation for in vitro fertilization with ICSI: a case report | 31.7 | 0 | 2 |
| Effect of endometrial biopsy on intrauterine insemination outcome in controlled ovarian stimulation cycle | 31.7 | 0 | 2 |
| Doctors' Preferences for Controlled Ovarian Stimulation Protocols in Intrauterine Insemination | 31.7 | 0 | 2 |
| New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators | 31.7 | 0 | 2 |
| Outcomes of ovarian stimulation after treatment with chemotherapy | 31.7 | 0 | 2 |
| Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer | 31.7 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| Best Practices for Controlled Ovarian Stimulation in In Vitro Fertilization | 31.7 | 0 | 2 |
| GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET). | 31.7 | 0 | 2 |
| Efficacy of oxytocin antagonist infusion in improving in vitro fertilization outcomes on the day of embryo transfer: A meta-analysis | 31.7 | 0 | 2 |
| Egg donation brokers: an analysis of agency versus in vitro fertilization clinic websites | 31.7 | 0 | 2 |
| Birth of rhesus monkey infant after in vitro fertilization and nonsurgical embryo transfer | 31.7 | 0 | 2 |
| A case of primary ovarian pregnancy after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Comparison of the role of cervical and intrauterine insemination techniques on the incidence of multiple pregnancy after artificial insemination with donor sperm | 31.7 | 0 | 2 |
| Reduced in vitro fertilization of human oocytes correlates with raised circulating FSH levels during ovarian stimulation in normogonadotropic women downregulated with GnRH-analogues | 31.7 | 0 | 2 |
| Effects of cryopreserved semen quality and timed intrauterine insemination on pregnancy rate and gender of offspring in a donor insemination program | 31.7 | 0 | 2 |
| A successful pregnancy with in vitro fertilization and embryo transfer in an infertile woman with Kartagener's syndrome: a case report | 31.7 | 0 | 2 |
| Contamination of embryo transfer catheter and treatment outcome in in vitro fertilization | 31.7 | 0 | 2 |
| Differences in female and male perception of information and decision-making in single-embryo transfer in in vitro fertilization in Sweden | 31.7 | 0 | 2 |
| Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications fo | 31.7 | 0 | 2 |
| Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction | 31.7 | 0 | 2 |
| Autologous endometrial co-culture in patients with repeated failures of implantation after in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| The reproductive performance of women with hypogonadotropic hypogonadism in an in vitro fertilization and embryo transfer program | 31.7 | 0 | 2 |
| Involvement of interleukin-1 and the interleukin-1 receptor antagonist in in vitro embryo development among women undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Early hormonal markers of pregnancy outcome after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Abdominal ultrasound-guided embryo transfer improves clinical pregnancy rates after in vitro fertilization: experiences from 330 clinical investigations | 31.7 | 0 | 2 |
| Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF). | 31.7 | 0 | 2 |
| Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). | 31.7 | 0 | 2 |
| Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Defining women who are prone to have twins in in vitro fertilization--a necessary step towards single embryo transfer | 31.7 | 0 | 2 |
| Bilateral ovarian pregnancy after in vitro fertilization and embryo transfer in a patient with tubal factor infertility | 31.7 | 0 | 2 |
| The effect of smoking on oocyte quality and hormonal parameters of patients undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Prediction of pregnancy rate of in vitro fertilization and embryo transfer in women aged 40 and over with basal uterine artery pulsatility index | 31.7 | 0 | 2 |
| Subpopulations of human granulosa-luteal cells obtained from gonadotropin- or gonadotropin-releasing hormone agonist/gonadotropin-treated follicles in in vitro fertilization-embryo transfer cycles | 31.7 | 0 | 2 |
| Seasonal influences on in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles | 31.7 | 0 | 2 |
| Is intracytoplasmic sperm injection necessary for couples undergoing in vitro fertilization-embryo transfer with normal semen analyses but failing hamster egg penetration assays? | 31.7 | 0 | 2 |
| Day 6 estradiol level predicts cycle cancellation among poor responder patients undergoing in vitro fertilization-embryo transfer cycles using a gonadotropin-releasing hormone agonist flare regimen | 31.7 | 0 | 2 |
| Effect of a sonographically diffusely enlarged uterus without distinct uterine masses on the outcome of in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles | 31.7 | 0 | 2 |
| Combined intrauterine, tubal, and cervical pregnancies following in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Birth of a healthy infant after in vitro fertilization and embryo transfer in patient of total uterine prolapse | 31.7 | 0 | 2 |
| Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles | 31.7 | 0 | 2 |
| Review of scientific contributions by the Belgian medical centers concerned with human in vitro fertilization and embryo transfer (IVF) | 31.7 | 0 | 2 |
| Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Clinical significance of transvaginal color Doppler ultrasonography of the ovarian artery as a predictor of ovarian response in controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Recruiting egg donors online: an analysis of in vitro fertilization clinic and agency websites' adherence to American Society for Reproductive Medicine guidelines | 31.7 | 0 | 2 |
| Mature oocyte retrieval during laparotomic debulking surgery following random-start controlled ovarian stimulation for fertility preservation in a patient with suspected ovarian cancer | 31.7 | 0 | 2 |
| Ovarian stimulation with human and recombinant gonadotropin – comparison of in vitro fertilization efficiency with use of time-lapse monitoring | 31.7 | 0 | 2 |
| The science behind 25 years of ovarian stimulation for in vitro fertilization | 31.7 | 0 | 2 |
| Overt leptin response to controlled ovarian hyperstimulation negatively correlates with pregnancy outcome in in vitro fertilization--embryo transfer cycle | 31.7 | 0 | 2 |
| Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons | 31.7 | 0 | 2 |
| Associations between paternal urinary phthalate metabolite concentrations and reproductive outcomes among couples seeking fertility treatment | 31.7 | 0 | 2 |
| Oncofertility: a grand collaboration between reproductive medicine and oncology | 31.7 | 0 | 2 |
| Intrauterine insemination catheters for assisted reproduction: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| Clustering of monozygotic twinning in IVF | 31.7 | 0 | 2 |
| The prevalence of positive urinary cotinine tests in Korean infertile couples and the effect of smoking on assisted conception outcomes | 31.7 | 0 | 2 |
| Anti-Müllerian hormone levels as a predictor of clinical pregnancy inin vitrofertilization/intracytoplasmic sperm injection-embryo transfer cycles in patients over 40 years of age | 31.7 | 0 | 2 |
| Second-trimester heterotopic pregnancy after in vitro fertilization and embryo transfer--a case report and review of the literature. | 31.7 | 0 | 2 |
| Human in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Effect of Cancer on Ovarian Function in Patients Undergoing In Vitro Fertilization for Fertility Preservation: A Reappraisal | 31.7 | 0 | 2 |
| Dairy intake in relation to in vitro fertilization outcomes among women from a fertility clinic. | 31.7 | 0 | 2 |
| Evidence that exposure to progesterone alone is a sufficient stimulus to cause a precipitous rise in the immunomodulatory protein the progesterone induced blocking factor (PIBF) | 31.7 | 0 | 2 |
| In vitro maturation of human oocytes for assisted reproduction | 31.7 | 0 | 2 |
| Preliminary data on our experience of in vitro fertilization-embryo transfer in the treatment of sterility | 31.7 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 31.7 | 0 | 2 |
| Effects of culture media conditions on production of eggs fertilized in vitro of embryos derived from ovary of high grade Hanwoo | 31.7 | 0 | 2 |
| Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. | 31.7 | 0 | 2 |
| Mild ovarian stimulation for in vitro fertilization: one perspective from the USA | 31.7 | 0 | 2 |
| Can cycle day 7 FSH concentration during controlled ovarian stimulation be used to guide FSH dosing for in vitro fertilization? | 31.7 | 0 | 2 |
| A logistic model to predict early pregnancy loss following in vitro fertilization based on 2601 infertility patients | 31.7 | 0 | 2 |
| The impact of patient preselection on reported IVF outcomes | 31.7 | 0 | 2 |
| Risk of repeated spontaneous luteinizing hormone surges in ovarian stimulation for in vitro fertilization | 31.7 | 0 | 2 |
| A case of Baller-Gerold syndrome following in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Economic Evaluation of In Vitro Fertilization with Embryo Transfer and Neosalpingostomy by Laparotomy or Laparoscopy | 31.7 | 0 | 2 |
| Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles | 31.7 | 0 | 2 |
| Recent data on the treatment of unexplained infertility with clomiphene citrate, intrauterine insemination, and in vitro fertilization | 31.7 | 0 | 2 |
| The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET). | 31.7 | 0 | 2 |
| A novel approach to quantifying ovarian cell lipid content and lipid accumulation in vitro by confocal microscopy in lean women undergoing ovarian stimulation for in vitro fertilization (IVF). | 31.7 | 0 | 2 |
| Reluctance of medical professionals in adopting natural-cycle and minimal ovarian stimulation protocols in human clinical assisted reproduction | 31.7 | 0 | 2 |
| Does a strategy to promote shared decision-making reduce medical practice variation in the choice of either single or double embryo transfer after in vitro fertilisation? A secondary analysis of a randomised controlled trial | 31.7 | 0 | 2 |
| The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome | 31.7 | 0 | 2 |
| Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report | 31.7 | 0 | 2 |
| Outcomes of intracytoplasmic sperm injection using the zona pellucida-bound sperm or manually selected sperm | 31.7 | 0 | 2 |
| Time-lapse variables and embryo gender: a retrospective analysis of 81 live births obtained following minimal stimulation and single embryo transfer | 31.7 | 0 | 2 |
| A Case of Secondary Abdominal Pregnancy after in Vitro Fertilization Pre-Embryo Transfer (IVF-ET). | 31.7 | 0 | 2 |
| Cryopreservation/transplantation of ovarian tissue and in vitro maturation of follicles and oocytes: challenges for fertility preservation | 31.7 | 0 | 2 |
| Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue | 31.7 | 0 | 2 |
| Rescue in vitro fertilization using a GnRH antagonist in hyper-responders from gonadotropin intrauterine insemination (IUI) cycles | 31.7 | 0 | 2 |
| Association of progesterone receptor polymorphisms with recurrent implantation failure after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Hyaluronan in follicular fluid and embryo implantation following in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Stimulated intrauterine insemination (SIUI) and donor insemination (DI) as first line management for a selected subfertile population: the Manchester experience | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer: a brief overview | 31.7 | 0 | 2 |
| Estimating rates of multiple gestation pregnancies: sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial | 31.7 | 0 | 2 |
| Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles. | 31.7 | 0 | 2 |
| Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization | 31.7 | 0 | 2 |
| Impact of different embryo loading techniques on pregnancy rates in in vitro fertlization/embryo transfer cycles | 31.7 | 0 | 2 |
| The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles | 31.7 | 0 | 2 |
| Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index | 31.7 | 0 | 2 |
| The total pregnancy potential per oocyte aspiration after assisted reproduction—in how many cycles are biologically competent oocytes available? | 31.7 | 0 | 2 |
| Safety of assisted reproduction, assessed by risk of abnormalities in children born after use of in vitro fertilization techniques | 31.7 | 0 | 2 |
| Previous tubal ectopic pregnancy raises the incidence of repeated ectopic pregnancies in in vitro fertilization-embryo transfer patients | 31.7 | 0 | 2 |
| Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles | 31.7 | 0 | 2 |
| Complications in pregnancies after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| A comparison of the cost-effectiveness of in vitro fertilization strategies and stimulated intrauterine insemination in a Canadian health economic model. | 31.7 | 0 | 2 |
| Ovarian stimulation for in vitro fertilization alters the protein profile expression in endometrial secretion | 31.7 | 0 | 2 |
| Pregnancy, Delivery, and Neonatal Outcomes of In Vitro Fertilization-Embryo Transfer in Patient with Previous Cesarean Scar. | 31.7 | 0 | 2 |
| Assisted reproduction and fertility preservation techniques in cancer patients | 31.7 | 0 | 2 |
| Human choriogonadotropin prior to controlled ovarian stimulation and in vitro fertilization improves implantation, and pregnancy rates | 31.7 | 0 | 2 |
| Clinical efficacy of body mass index as predictor of in vitro fertilization and embryo transfer outcomes | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 31.7 | 0 | 2 |
| Glycine supplementation in vitro enhances porcine preimplantation embryo cell number and decreases apoptosis but does not lead to live births | 31.7 | 0 | 2 |
| Comparison of easy and difficult embryo transfer outcomes in in vitro fertilization cycles | 31.7 | 0 | 2 |
| Heterotopic pregnancy following in vitro fertilization and embryo transfer: 12 cases report. | 31.7 | 0 | 2 |
| Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization | 31.7 | 0 | 2 |
| Endometrial signaling pathways during ovarian stimulation for assisted reproduction technology | 31.7 | 0 | 2 |
| comparison between Cleavage Stage versus Blastocyst Stage Embryo Transfer in an Egyptian Cohort Undergoing in vitro Fertilization: A possible Role for Laser Assisted Hatching | 31.7 | 0 | 2 |
| Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients | 31.7 | 0 | 2 |
| Two successful pregnancies achieved by converting an in vitro fertilization cycle to an intrauterine insemination cycle in five cases with documented premature ovulation | 31.7 | 0 | 2 |
| Reduced protein C Global assay level in infertile women prior to IVF-ET treatment | 31.7 | 0 | 2 |
| Improvement of pregnancy rate by intrauterine administration of dexamethasone and recombinant human leukemia inhibitory factor at the time of embryo transfer in cattle | 31.7 | 0 | 2 |
| Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilisation cycles: a prospective study | 31.7 | 0 | 2 |
| Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome | 31.7 | 0 | 2 |
| Quality of embryos transferred and progesterone levels are the most important predictors of live birth after fresh embryo transfer: a retrospective cohort study | 31.7 | 0 | 2 |
| Fertility preservation with immature and in vitro matured oocytes | 31.7 | 0 | 2 |
| Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms | 31.7 | 0 | 2 |
| Hysterectomy in the Second Trimester of Pregnancy after In vitro Fertilization-embryo Transfer: A Case Report and Analysis of Its Risk Factors | 31.7 | 0 | 2 |
| 21-Hydroxylase-derived steroids in follicles of nonobese women undergoing ovarian stimulation for in vitro fertilization (IVF) positively correlate with lipid content of luteinized granulosa cells (LGCs) as a source of cholesterol for steroid synthe | 31.7 | 0 | 2 |
| Relationship of serum progesterone (P) level the day after human chorionic gonadotropin (hCG) injection on outcome following in vitro fertilization-embryo transfer (IVF-ET). | 31.7 | 0 | 2 |
| Severe systemic candidiasis following immunomodulation therapy in in vitro fertilisation-embryo transfer (IVF-ET) | 31.7 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 31.7 | 0 | 2 |
| Inositol and In Vitro Fertilization with Embryo Transfer | 31.7 | 0 | 2 |
| Blastocyst Transfer Ameliorates Live Birth Rate Compared with Cleavage-Stage Embryos Transfer in FreshIn VitroFertilization or Intracytoplasmic Sperm Injection Cycles: Reviews and Meta-Analysis | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Random start or emergency IVF/in vitro maturation: a new rapid approach to fertility preservation | 31.7 | 0 | 2 |
| Improving fertility preservation for girls and women by coupling oocyte in vitro maturation with existing strategies | 31.7 | 0 | 2 |
| Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery | 31.7 | 0 | 2 |
| Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation | 31.7 | 0 | 2 |
| In vitro fertilization-embryo transfer in nonhuman primates: the technique and its applications | 31.7 | 0 | 2 |
| Fertility preservation and infertility treatment in breast cancer patients | 31.7 | 0 | 2 |
| In vitro maturation of oocytes as a strategy for fertility preservation | 31.7 | 0 | 2 |
| Ectopic pregnancy following in vitro fertilisation and embryo transfer. | 31.7 | 0 | 2 |
| Oocyte cryopreservation as a fertility preservation measure for cancer patients | 31.7 | 0 | 2 |
| Does serologic evidence of remote Chlamydia trachomatis infection and its heat shock protein (CHSP 60) affect in vitro fertilization-embryo transfer outcome? | 31.7 | 0 | 2 |
| Infection control considerations for in vitro fertilization and embryo transfer programs | 31.7 | 0 | 2 |
| Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction | 31.7 | 0 | 2 |
| Multiple births from fertility treatment in the UK: A Consensus statement | 31.7 | 0 | 2 |
| Elective single-embryo transfer | 31.7 | 0 | 2 |
| Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature | 31.7 | 0 | 2 |
| Ovarian stimulation and intrauterine insemination at the quarter centennial: implications for the multiple births epidemic | 31.7 | 0 | 2 |
| Full in vitro fertilization laboratory mechanization: toward robotic assisted reproduction? | 31.7 | 0 | 2 |
| Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer | 31.7 | 0 | 2 |
| New Trends in Female Fertility Preservation: In Vitro Maturation of Oocytes | 31.7 | 0 | 2 |
| Term delivery following tuboovarian abscess after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| In vitro maturation: a committee opinion | 31.7 | 0 | 2 |
| Ovarian stem cells—Potential roles in infertility treatment and fertility preservation | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| The wobbly evidence base of reproductive medicine | 31.7 | 0 | 2 |
| In Vitro Activation of Dormant Follicles for Fertility Preservation | 31.7 | 0 | 2 |
| The role of ultrasonography in in-vitro fertilization and embryo transfer (IVF-ET) | 31.7 | 0 | 2 |
| Mild ovarian stimulation for in vitro fertilization: are we ready to change? A meta-analysis | 31.7 | 0 | 2 |
| Misconduct in third-party assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| VACTERL association with hydrocephalus in a fetus conceived by in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. | 31.7 | 0 | 2 |
| Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer | 31.7 | 0 | 2 |
| Acupuncture in IVF: A review of current literature | 31.7 | 0 | 2 |
| Role of assisted hatching in in vitro fertilization: a guideline | 31.7 | 0 | 2 |
| Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Methods employed to overcome difficult embryo transfer during assisted reproduction treatment | 31.7 | 0 | 2 |
| Anticoagulation and in vitro fertilization and ovarian stimulation | 31.7 | 0 | 2 |
| Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination | 31.7 | 0 | 2 |
| Childlessness, parental mortality and psychiatric illness: a natural experiment based on in vitro fertility treatment and adoption | 31.7 | 0 | 2 |
| The importance of the length of uterine cavity, the position of the tip of the inner catheter and the distance between the fundal endometrial surface and the air bubbles as determinants of the pregnancy rate in IVF cycles | 31.7 | 0 | 2 |
| Clinical aspects of 7 pregnancies following in vitro fertilization and embryo transfer (IVF/ET) | 31.7 | 0 | 2 |
| Emergency fertility preservation for female patients with cancer: clinical perspectives | 31.7 | 0 | 2 |
| Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients | 31.7 | 0 | 2 |
| A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilizatio | 31.7 | 0 | 2 |
| Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone | 31.7 | 0 | 2 |
| Treatment with piroxicam before embryo transfer increases the pregnancy rate after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| The clinical efficacy and efficiency of a 100-IU starting dose of recombinant follicle stimulating hormone (Puregon) in Korean women undergoing in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Influence of female age on pregnancy outcome in in vitro fertilization and embryo transfer patients undergoing intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| Simultaneous program of natural-cycle in vitro fertilization and cryopreserved-thawed embryo transfer | 31.7 | 0 | 2 |
| The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins | 31.7 | 0 | 2 |
| Subclinical hypothyroidism in the infertile female population: a guideline | 31.7 | 0 | 2 |
| In Vitro Fertilization for Endometriosis-Associated Infertility | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer in domestic animals: applications in animals and implications for humans | 31.7 | 0 | 2 |
| Comparison of neonatal outcomes following progesterone use during ovarian stimulation with frozen-thawed embryo transfer | 31.7 | 0 | 2 |
| Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy | 31.7 | 0 | 2 |
| Impact of equine assisted reproductive technologies (standard embryo transfer or intracytoplasmic sperm injection (ICSI) with in vitro culture and embryo transfer) on placenta and foal morphometry and placental gene expression. | 31.7 | 0 | 2 |
| Leptin and its potential interest in assisted reproduction cycles | 31.7 | 0 | 2 |
| Effect of music therapy on the anxiety levels and pregnancy rate of women undergoing in vitro fertilization-embryo transfer: A randomized controlled trial. | 31.7 | 0 | 2 |
| Heterotopic Pregnancy After In Vitro Fertilization and Embryo Transfer After Bilateral Total Salpingectomy/Tubal Ligation: Case Report and Literature Review | 31.7 | 0 | 2 |
| In Vitro Activation: A Possible New Frontier for Treatment of Primary Ovarian Insufficiency | 31.7 | 0 | 2 |
| Psychological studies of in vitro fertilization/embryo transfer participants | 31.7 | 0 | 2 |
| The effect of peri-implantation administration of uterine relaxing agents in assisted reproduction treatment cycles: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| Infertility in advanced reproductive age. Results of in vitro fertilization and embryo transfer according to the woman's age. | 31.7 | 0 | 2 |
| Mature Oocyte Cryopreservation for Fertility Preservation | 31.7 | 0 | 2 |
| Female fertility preservation strategies: cryopreservation and ovarian tissue in vitro culture, current state of the art and future perspectives | 31.7 | 0 | 2 |
| Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response | 31.7 | 0 | 2 |
| Fertility Treatment, Use of in Vitro Fertilization, and Time to Live Birth Based on Initial Provider Type | 31.7 | 0 | 2 |
| Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 31.7 | 0 | 2 |
| The effects of surgery for endometriosis on pregnancy outcomes following in vitro fertilization and embryo transfer: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| History of ABVD alters the number of oocytes vitrified after in vitro maturation in fertility preservation candidates | 31.7 | 0 | 2 |
| Predictive factors for pregnancy outcome following controlled ovarian stimulation and intrauterine insemination | 31.7 | 0 | 2 |
| Ovarian Stimulation, Intrauterine Insemination, Multiple Pregnancy and Major Congenital Malformations: A Systematic Review and Meta- Analysis- The ART_Rev Study | 31.7 | 0 | 2 |
| Ectopic pregnancy following in vitro fertilization with embryo transfer: A single-center experience during 15 years | 31.7 | 0 | 2 |
| In Vitro Fertilization Versus Mild Stimulation Intrauterine Insemination in Women Aged 40 and Older | 31.7 | 0 | 2 |
| Emergent Oocyte Cryopreservation with a Novel Ovarian Transposition Technique in a Colorectal Cancer Patient: A Combined Approach for Fertility Preservation. A Case Report | 31.7 | 0 | 2 |
| Oocyte cryopreservation for fertility preservation in women with cancer | 31.7 | 0 | 2 |
| RNA-Seq-Based Transcriptome Analysis of Changes in Gene Expression Linked to Human Pregnancy Outcome After In Vitro Fertilization—Embryo Transfer | 31.7 | 0 | 2 |
| Evaluation of genetic components in traits related to superovulation, in vitro fertilization, and embryo transfer in Holstein cattle. | 31.7 | 0 | 2 |
| Impact of monozygotic twinning on multiple births resulting from in vitro fertilization in the United States, 2006–2010 | 31.7 | 0 | 2 |
| Endometrial scratching for women with previous IVF failure undergoing IVF treatment | 31.7 | 0 | 2 |
| Urinary triclosan concentrations and early outcomes of in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers | 31.7 | 0 | 2 |
| Ovarian Stimulation for IVF: Mild Approaches | 31.7 | 0 | 2 |
| Performing the embryo transfer: a guideline | 31.7 | 0 | 2 |
| Effect of smoking on ovarian reserve and ovarian stimulation in in- vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Organization and computerized analysis of in vitro fertilization and embryo transfer programs | 31.7 | 0 | 2 |
| Correlation of visfatin levels and lipoprotein lipid profiles in women with polycystic ovary syndrome undergoing ovarian stimulation | 31.7 | 0 | 2 |
| Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion | 31.7 | 0 | 2 |
| The case for aromatase inhibitors use in Oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in Breast Cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate | 31.7 | 0 | 2 |
| Bed rest after embryo transfer negatively affects in vitro fertilization: a randomized controlled clinical trial | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer in Egypt | 31.7 | 0 | 2 |
| Dropout rates in couples undergoing in vitro fertilization and intrauterine insemination | 31.7 | 0 | 2 |
| Patient selection for in vitro fertilization (IVF) and embryo transfer (ET). | 31.7 | 0 | 2 |
| Comparative analysis of in vitro fertilization methods for establishing successful embryo transfer clinics | 31.7 | 0 | 2 |
| Some legal implications of embryo transfer | 31.7 | 0 | 2 |
| Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer | 31.7 | 0 | 2 |
| Predicting personalized multiple birth risks after in vitro fertilization-double embryo transfer | 31.7 | 0 | 2 |
| Problems related to the laboratory part of treatment by in vitro fertilization and embryo transfer. | 31.7 | 0 | 2 |
| A glance into the uterus during in vitro simulation of embryo transfer | 31.7 | 0 | 2 |
| Normal birth after single-embryo transfer in a patient with excessive polypronuclear zygote formation following in vitro fertilization and intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria | 31.7 | 0 | 2 |
| Can we identify subfertile couples that benefit from immediate in vitro fertilisation over intrauterine insemination? | 31.7 | 0 | 2 |
| In vitro maturation and fertilization of vitrified immature human oocytes, subsequent vitrification of produced embryos, and embryo transfer after thawing | 31.7 | 0 | 2 |
| Ultrasound‐guided aspiration of hydrosalpinx occurring during controlled ovarian hyperstimulation could improve clinical outcome of in vitro fertilization–embryo transfer | 31.7 | 0 | 2 |
| Use of sexed sorted semen for fixed-time artificial insemination or fixed-time embryo transfer of in vitro–produced embryos in cattle | 31.7 | 0 | 2 |
| Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40-42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report | 31.7 | 0 | 2 |
| Clinical outcomes of frozen-thawed single blastocyst transfer in patients requiring whole embryo freezing | 31.7 | 0 | 2 |
| Patients’ Evaluation of Intervention by a Medical Clown Visit or by Viewing a Humorous Film Following In Vitro Fertilization and Embryo Transfer | 31.7 | 0 | 2 |
| Improved in vitro model systems for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditions | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer program, Department of Obstetrics and Gynecology, University of Adelaide at the Queen Elizabeth Hospital, Woodville, South Australia | 31.7 | 0 | 2 |
| Catastrophic payment for assisted reproduction techniques with conventional ovarian stimulation in the public health sector of South Africa: frequency and coping strategies | 31.7 | 0 | 2 |
| Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? | 31.7 | 0 | 2 |
| Concepts in human in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Safety versus success in elective single embryo transfer: women's preferences for outcomes of in vitro fertilisation | 31.7 | 0 | 2 |
| In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation | 31.7 | 0 | 2 |
| Risk of Coxiella burnetii transmission via embryo transfer using in vitro early bovine embryos | 31.7 | 0 | 2 |
| In vitro fertilization: problems in culture conditions and embryo transfer. | 31.7 | 0 | 2 |
| History of biochemical pregnancy was associated with the subsequent reproductive failure among women with recurrent spontaneous abortion | 31.7 | 0 | 2 |
| Can dicoumarol be used as a gonad-safe anticancer agent: anin vitroandin vivoexperimental study | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Current status of in vitro fertilization and embryo transfer in man. | 31.7 | 0 | 2 |
| Mitochondrial D-loop Variations in Infertile Women Undergoing in Vitro Fertilization-Embryo Transfer | 31.7 | 0 | 2 |
| Helping parents to tell their children about the use of donor insemination (DI) and determining their opinions about open-identity sperm donors | 31.7 | 0 | 2 |
| Obstetrics and gynecology: in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction? | 31.7 | 0 | 2 |
| T-helper 2 and 3 type immunity to trophoblast in successful in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Fertility preservation and reproduction in cancer patients | 31.7 | 0 | 2 |
| Low-versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program | 31.7 | 0 | 2 |
| Retrospective analysis of 6 cases of miliary tuberculosis in pregnant women after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Heterotopic pregnancy following administration of human menopausal gonadotropin and following in vitro fertilization and embryo transfer: two case reports and review of the literature | 31.7 | 0 | 2 |
| Mid-luteal phase injection of subcutaneous leuprolide acetate improves live delivered pregnancy and implantation rates in younger women undergoing in vitro fertilization-embryo transfer (IVF-ET). | 31.7 | 0 | 2 |
| The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program | 31.7 | 0 | 2 |
| Progress of research on in vitro fertilization and embryo transfer in China. | 31.7 | 0 | 2 |
| Cumulative number and morphological score of embryos resulting in success: realistic expectations from in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Physical health of singleton children born after frozen embryo transfer using slow freezing: a 3-year follow-up study | 31.7 | 0 | 2 |
| Cycle-to-cycle variation in utero-ovarian hemodynamic indices in ovarian stimulation and natural cycles of the same women and its effect on the outcome of assisted reproduction treatment. | 31.7 | 0 | 2 |
| The relationship between the changes in the level of progesterone and the outcome ofin vitrofertilization-embryo transfer | 31.7 | 0 | 2 |
| Use of recombinant human follicle-stimulating hormone for in vitro fertilization-embryo transfer after severe systemic immunoglobulin E-mediated reaction to urofollitropin | 31.7 | 0 | 2 |
| Do malignant diseases affect semen quality? Sperm parameters of men with cancers | 31.7 | 0 | 2 |
| Luteinizing hormone-releasing hormone agonists for ovarian stimulation in assisted reproduction | 31.7 | 0 | 2 |
| High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer. | 31.7 | 0 | 2 |
| Estimating cumulative live-birth rates after IVF treatment with Kaplan–Meier and competing risk methods | 31.7 | 0 | 2 |
| Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction | 31.7 | 0 | 2 |
| Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients. | 31.7 | 0 | 2 |
| In vitro fertilization outcome relative to embryo transfer difficulty: a novel approach to the forbidding cervix. | 31.7 | 0 | 2 |
| Therapeutic intrauterine insemination improves with gonadotropin ovarian stimulation | 31.7 | 0 | 2 |
| Reduced Circulating Concentration of Brain‐derived Neurotrophic Factor is Associated with Peri‐ and Post‐implantation Failure following In Vitro Fertilization–Embryo Transfer | 31.7 | 0 | 2 |
| The influence of number of embryos transferred on pregnancy outcome in women undergoing in vitro fertilization and embryo transfer (IVF-ET). | 31.7 | 0 | 2 |
| Strategy for the prevention of transfusion-transmitted hepatitis--current state of blood donor screening test | 31.7 | 0 | 2 |
| Ovarian stimulation for assisted reproduction | 31.7 | 0 | 2 |
| Significance of an abnormal response during pituitary desensitization in an in vitro fertilization and embryo transfer program | 31.7 | 0 | 2 |
| Stability of in vitro fertilization-embryo transfer success rates from the 1989, 1990, and 1991 Clinic-Specific Outcome Assessments | 31.7 | 0 | 2 |
| In vitro fertilization, gamete intrafallopian transfer, and superovulation with intrauterine insemination: efficacy and potential health hazards on babies delivered | 31.7 | 0 | 2 |
| Effect of Methotrexate or Salpingectomy for Ectopic Pregnancy on Subsequent In Vitro Fertilization–Embryo Transfer Outcomes | 31.7 | 0 | 2 |
| Effects of high progesterone on outcomes ofin vitrofertilization-embryo transfer in patients with different ovarian responses | 31.7 | 0 | 2 |
| Predictive value of maternal serum human chorionic gonadotropin levels in pregnancies achieved by in vitro fertilization with single cleavage and single blastocyst embryo transfers | 31.7 | 0 | 2 |
| The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program. | 31.7 | 0 | 2 |
| Risk of Colorectal Cancer After Ovarian Stimulation for In Vitro Fertilization | 31.7 | 0 | 2 |
| Ectopic pregnancies after in vitro fertilization and embryo transfer. | 31.7 | 0 | 2 |
| Mole modifications following controlled ovarian stimulation for assisted reproduction technologies | 31.7 | 0 | 2 |
| Cornual pregnancies in patients with prior salpingectomy undergoing in vitro fertilization and embryo transfer. | 31.7 | 0 | 2 |
| Factors affecting occurrence of twin pregnancy after double embryo transfer on day 3 | 31.7 | 0 | 2 |
| Very early pregnancy wastage in in vitro fertilization and embryo transfer (IVF-ET). | 31.7 | 0 | 2 |
| The prognostic value and significance of preclinical abortions in in vitro fertilization-embryo transfer programs. | 31.7 | 0 | 2 |
| Cocultures in human assisted reproduction. Support of embryos in vitro and their specificity | 31.7 | 0 | 2 |
| Current technology of in vitro fertilization and embryo transfer. | 31.7 | 0 | 2 |
| Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion | 31.7 | 0 | 2 |
| Melanoma risk after ovarian stimulation for in vitro fertilization. | 31.7 | 0 | 2 |
| Fertilization in vitro and embryo transfer (FIVET) and endometriosis. Uncertainties and issues | 31.7 | 0 | 2 |
| Effects of two human chorionic gonadotropin doses administered to the ovarian states during the in vitro fertilization and embryo transfer program | 31.7 | 0 | 2 |
| Transport of wild mice genetic material by in vitro fertilization, cryopreservation, and embryo transfer | 31.7 | 0 | 2 |
| Ovarian stimulation in assisted reproduction. | 31.7 | 0 | 2 |
| Attitudes toward egg donation of thirty-four infertile women who donated during their in vitro fertilization treatment | 31.7 | 0 | 2 |
| Relationship between donor sperm parameters and pregnancy outcome after intrauterine insemination: analysis of 2821 cycles in 1355 couples. | 31.7 | 0 | 2 |
| Clomiphene citrate is associated with favorable cycle characteristics but impaired outcomes of obese women with polycystic ovarian syndrome undergoing ovarian stimulation for in vitro fertilization | 31.7 | 0 | 2 |
| Factors influencing pregnancy rates following in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| The effect of porcine relaxin vaginally applied at human embryo transfer in an in vitro fertilization programme | 31.7 | 0 | 2 |
| Failure of implantation in human in vitro fertilization and embryo transfer patients: the effects of altered progesterone/estrogen ratios in humans and mice. | 31.7 | 0 | 2 |
| Influence of male age on the pregnancy outcomes of IVF-ET | 31.7 | 0 | 2 |
| Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials | 31.7 | 0 | 2 |
| Delayed appearance of plasmatic chorionic gonadotropin in pregnancies after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Fertility preservation for trans men: frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic spindles | 31.7 | 0 | 2 |
| Fertility preservation in women of the childbearing age: Indications and strategies | 31.7 | 0 | 2 |
| Cryopreservation ofin vitromatured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy | 31.7 | 0 | 2 |
| Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval | 31.7 | 0 | 2 |
| Can repeated IVF–ICSI-cycles be avoided by using blastocysts developing from poor-quality cleavage stage embryos? | 31.7 | 0 | 2 |
| Implantation of fresh and thawed–warmed embryos in single embryo transfer cycles: interpreting the initial beta-HCG | 31.7 | 0 | 2 |
| Developmental potential of zona pellucida–free oocytes obtained following mild in vitro fertilization | 31.7 | 0 | 2 |
| Comparative efficiency study of fresh and vitrified oocytes in egg donation programs for different controlled ovarian stimulation protocols | 31.7 | 0 | 2 |
| In vitro oocyte maturation for female fertility preservation | 31.7 | 0 | 2 |
| Birth of a domestic cat kitten produced by vitrification of lipid polarized in vitro matured oocytes | 31.7 | 0 | 2 |
| Optimal vitrification protocol for mouse ovarian tissue cryopreservation: effect of cryoprotective agents and in vitro culture on vitrified-warmed ovarian tissue survival | 31.7 | 0 | 2 |
| Oocyte cryopreservation and in vitro culture affect calcium signalling during human fertilization | 31.7 | 0 | 2 |
| Mature oocyte cryopreservation: a guideline | 31.7 | 0 | 2 |
| Vitrification of oocytes for in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| The yield of universal antibody to hepatitis B core antigen donor screening in theNetherlands, a hepatitis B virus low‐endemic country | 31.7 | 0 | 2 |
| Neonatal outcome and birth defects in 6623 singletons born following minimal ovarian stimulation and vitrified versus fresh single embryo transfer | 31.7 | 0 | 2 |
| Efficacy of embryo transfer in lactating dairy cows during summer using fresh or vitrified embryos produced in vitro with sex-sorted semen | 31.7 | 0 | 2 |
| Efficacy of in vitro embryo transfer in lactating dairy cows using fresh or vitrified embryos produced in a novel embryo culture medium | 31.7 | 0 | 2 |
| Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients | 31.7 | 0 | 2 |
| Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation | 31.7 | 0 | 2 |
| Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy | 31.7 | 0 | 2 |
| Vitrification of human cleaved embryos in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program | 31.7 | 0 | 2 |
| Pregnancy rates following timed embryo transfer with fresh or vitrified in vitro produced embryos in lactating dairy cows under heat stress conditions | 31.7 | 0 | 2 |
| Economic evaluation of elective single-embryo transfer with subsequent single frozen embryo transfer in an in vitro fertilization/intracytoplasmic sperm injection program | 31.7 | 0 | 2 |
| Sibling embryo blastocyst development correlates with the in vitro fertilization day 3 embryo transfer pregnancy rate in patients under age 40. | 31.7 | 0 | 2 |
| Gonadotropin Alone is a Better Drug for Ovarian Stimulation than in Combination with Clomiphene in Intrauterine Insemination | 31.7 | 0 | 2 |
| Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia | 31.7 | 0 | 2 |
| Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. | 31.7 | 0 | 2 |
| Secondary donation of frozen embryos is more common after pregnancy initiation with donated eggs than after in vitro fertilization-embryo transfer and gamete intrafallopian transfer | 31.7 | 0 | 2 |
| Effect of embryo freezing on perinatal outcome after assisted reproduction techniques: lessons from the Latin American Registry of Assisted Reproduction | 31.7 | 0 | 2 |
| Depression and coping strategies of Chinese women undergoing in-vitro fertilization | 31.7 | 0 | 2 |
| Superovulation-induced transient hyperprolactinemia in human in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Possibilities of ultrasound in the study of endometrial changes in cycle stimulation in the fertilization in vitro and embryo transfer programs | 31.7 | 0 | 2 |
| A Case of Unicornuate Uterus with Atypical Located Hyperstimulated Ovary after in Vitro Fertilization Pre-Embryo Transfer (IVF-ET). | 31.7 | 0 | 2 |
| The effect of the day of initiation of ovarian stimulation in the day of luteinizing hormone surge and outcome of in vitro fertilization. | 31.7 | 0 | 2 |
| Obstetrics and gynecology-important advances in clinical medicine: human in vitro fertilization and embryo transfer. | 31.7 | 0 | 2 |
| Heterotopic pregnancy associated with in vitro fertilization and embryo transfer: a possible role for routine vaginal ultrasound | 31.7 | 0 | 2 |
| Systematic inhibition of the luteinizing hormone with a gonadoliberin analog, triptorelin, during ovarian stimulation for fertilization in vitro. Choice of protocol | 31.7 | 0 | 2 |
| Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion | 31.7 | 0 | 2 |
| Heterotopic pregnancies after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 31.7 | 0 | 2 |
| Fertilization in vitro with frozen donor sperm after ovocyte stimulation with an LH-RH analog, HMG, and HCG using a short-term protocol | 31.7 | 0 | 2 |
| The impact of spermatic vein ligation on the male factor in in vitro fertilization-embryo transfer and its relation to testosterone levels before and after operation | 31.7 | 0 | 2 |
| Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization | 31.7 | 0 | 2 |
| Hepatitis B virus infection reduces fertilization ability during in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Tiaogeng Yijing decoction improves the pregnancy outcomes of patients with poor ovarian response undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| In vitro fertilization in older mothers: By choice or by law? | 31.7 | 0 | 2 |
| When looks are deceiving—the challenge facing embryo quality prognosticators | 31.7 | 0 | 2 |
| Preprogrammed, unmonitored ovarian stimulation reduces expense without compromising the outcome of assisted reproduction | 31.7 | 0 | 2 |
| Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization | 31.7 | 0 | 2 |
| Treatment of infertile women with unilateral tubal occlusion by intrauterine insemination and ovarian stimulation | 31.7 | 0 | 2 |
| Telomerase activity is more significant for predicting the outcome of IVF treatment than telomere length in granulosa cells | 31.7 | 0 | 2 |
| Luteal phase following oocyte aspiration, in vitro fertilization, and embryo transfer in clomid/HCG-stimulated cycles | 31.7 | 0 | 2 |
| Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients. | 31.7 | 0 | 2 |
| Follicular fluid steroid content and in vitro steroid secretion by granulosa-lutein cells from individual follicles among different stimulation protocols for in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Prognosis of oocyte donation cycles: a prospective comparison of the in vitro fertilization-embryo transfer cycles of recipients who used shared oocytes versus those who used altruistic donors | 31.7 | 0 | 2 |
| Comparison of pregnancy rates following in vitro fertilization-embryo transfer between the donors and the recipients in a donor oocyte program | 31.7 | 0 | 2 |
| Physicians should be more open-minded about performing in vitro fertilization-embryo transfer in women with diminished oocyte reserve and consider the couple's wishes and desires | 31.7 | 0 | 2 |
| A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. | 31.7 | 0 | 2 |
| Delivery rates following IVF treatment, using two recombinant FSH preparations for ovarian stimulation | 31.7 | 0 | 2 |
| IVF Treatment and Single Embryo Transfer | 31.7 | 0 | 2 |
| Preconception Steroid Treatment in Infertile Women with Antithyroid Autoimmunity Undergoing Ovarian Stimulation and Intrauterine Insemination: A Double-Blind, Randomized, Prospective Cohort Study | 31.7 | 0 | 2 |
| Modified Natural Cycle for In Vitro Fertilization and Embryo Transfer in Normal Ovarion Responders | 31.7 | 0 | 2 |
| Effects of body mass index and age on the treatment of in vitro fertilization-embryo transfer among patients with non-polycystic ovarian syndrome | 31.7 | 0 | 2 |
| Association of the change in serum estradiol (E2) levels from the day of to the day after human chorionic gonadotropin (hCG) injection and pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in less than average responders | 31.7 | 0 | 2 |
| Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Comparison of Alarelin and Triptorelin in the long-protocol ovulation induction in in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| A prospective clinical study of interventional ultrasound sclerotherapy on women with hydrosalpinx before in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Tubercular Ascites Simulating Ovarian Hyperstimulation Syndrome following In Vitro Fertilization and Embryo Transfer Pregnancy. | 31.7 | 0 | 2 |
| Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles | 31.7 | 0 | 2 |
| Efficacy of the International Embryo Transfer Society (IETS) washing procedure for rendering oocytes matured in vitro free of bovine viral diarrhea virus (BVDV) | 31.7 | 0 | 2 |
| Impaired ovarian stimulation during in vitro fertilization in women who are seropositive for hepatitis C virus and seronegative for human immunodeficiency virus | 31.7 | 0 | 2 |
| In vitro fertilisation for all? Fertility treatment may be an economic blessing | 31.7 | 0 | 2 |
| Assisted reproduction: an important review of the literature on the risk of malformation after in vitro fertilization and intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| Effect of er'zhi tiangui granule on metabonomics and level of Ca2+ in follicle fluid in patients after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization–embryo transfer cycles: a prospective randomized study | 31.7 | 0 | 2 |
| Intramuscular vs intravaginal natural progesterone in patients undergoing in vitro fertilization-embryo transfer cycles. A retrospective observational, case-control study | 31.7 | 0 | 2 |
| Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study | 31.7 | 0 | 2 |
| Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study. | 31.7 | 0 | 2 |
| Reproduction after breast cancer | 31.7 | 0 | 2 |
| Oocyte cryopreservation after controlled ovarian hyperstimulation in mosaic Turner syndrome: another fertility preservation option in a dedicated UK clinic | 31.7 | 0 | 2 |
| Excessive ovarian stimulation up-regulates the Wnt-signaling molecule DKK1 in human endometrium and may affect implantation: an in vitro co-culture study | 31.7 | 0 | 2 |
| Effects of electroacupuncture on in vitro fertilization-embryo transfer (IVF-ET) of patients with poor ovarian response | 31.7 | 0 | 2 |
| First live birth following IVF-embryo transfer and use of GnRHa alone for ovarian stimulation | 31.7 | 0 | 2 |
| Tubal ectopic pregnancy after in vitro fertilization and embryo transfer: a role for proximal occlusion or salpingectomy after failed distal tubal surgery? | 31.7 | 0 | 2 |
| Live birth of healthy triplets after in vitro fertilization and embryo transfer in an acromegalic woman with elevated growth hormone | 31.7 | 0 | 2 |
| Immunosuppressive activity in human in vitro fertilization (IVF) culture supernatants and prediction of the outcome of embryo transfer: a multicenter trial | 31.7 | 0 | 2 |
| Luteal phase support for in vitro fertilization-embryo transfer--present and future methods to improve successful implantation | 31.7 | 0 | 2 |
| Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction | 31.7 | 0 | 2 |
| Twin classics: research that always inspires/Twin studies: elder twin relationships; Superfecundated twinning in chimpanzees; Conjoined twinning and embryo transfer; Reduced frequency of in vitro multiples/Professional and human interest: first iden | 31.7 | 0 | 2 |
| First full-term pregnancy after in vitro fertilization and embryo reimplantation. The In Vitro Fertilization-Embryo Transfer Group of Torino | 31.7 | 0 | 2 |
| Perinatal morbidity after in vitro fertilization is lower with frozen embryo transfer | 31.7 | 0 | 2 |
| Granulosa-luteal cell function in vitro and ovarian stimulation protocols | 31.7 | 0 | 2 |
| Singleton pregnancy outcomes after in vitro fertilization with fresh or frozen-thawed embryo transfer and incidence of placenta praevia. | 31.7 | 0 | 2 |
| Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit | 31.7 | 0 | 2 |
| Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran | 31.7 | 0 | 2 |
| Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| Comparison of 2 therapeutic strategies in severe endometriosis, in young women consulting for sterility or pain. II. In the case of infertility, value of ovarian stimulation with intrauterine insemination after surgery | 31.7 | 0 | 2 |
| Morphology of seminal and swim-up spermatozoa and the outcome of in vitro fertilization and embryo transfer. | 31.7 | 0 | 2 |
| Assessment of follicular maturity by follicular diameter and fluid volume in a program of in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Relationship of antibodies to sperm head to etiology of infertility in patients undergoing in vitro fertilization/embryo transfer | 31.7 | 0 | 2 |
| Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Life after unsuccessful IVF treatment in an assisted reproduction unit: a qualitative analysis of gains through loss among Chinese persons in Hong Kong. | 31.7 | 0 | 2 |
| Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. | 31.7 | 0 | 2 |
| Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist | 31.7 | 0 | 2 |
| A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles | 31.7 | 0 | 2 |
| In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular response falls short of expectation? | 31.7 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 31.7 | 0 | 2 |
| A case of multiple (5) ectopic pregnancies, ultimately resulting in a twin pregnancy after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Special aspects of ovarian stimulation and in vitro fertilization | 31.7 | 0 | 2 |
| Case report: treatment of congenital vas obstruction with sperm aspiration, nonstimulated in vitro fertilization, and nonsurgical tubal embryo transfer | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer at the community hospital in Arhus | 31.7 | 0 | 2 |
| Intrauterine insemination using cryopreserved donor sperm, a methods which increases therapeutic success | 31.7 | 0 | 2 |
| A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles | 31.7 | 0 | 2 |
| Acceptability and value of autoinjection of gonadotropins for ovarian stimulation in intrauterine insemination | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer: two-year experience | 31.7 | 0 | 2 |
| A Comparison of Immigrant and Canadian-Born Patients Seeking Fertility Treatment | 31.7 | 0 | 2 |
| Policy positions on in vitro fertilization and embryo transfer in human individuals (German Democratic Republic, 1985). | 31.7 | 0 | 2 |
| Ectopic tubal pregnancy following in vitro fertilization and embryo transfer under ultrasonic control. | 31.7 | 0 | 2 |
| An analysis of factors associated with ectopic pregnancy following in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Serum prolactin response to embryo transfer during human in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Use of computer analysis in the program of in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| The in vitro fertilization and embryo transfer program at the First Women's Hospital "T. Kirkova," Sofia, Bulgaria | 31.7 | 0 | 2 |
| Human in vitro fertilization and embryo transfer program at the Medical Academy, Sofia, Bulgaria | 31.7 | 0 | 2 |
| Conversion of high-response gonadotropin intrauterine insemination cycles to in vitro fertilization results in excellent ongoing pregnancy rates. | 31.7 | 0 | 2 |
| Transvaginal ultrasound-guided embryo transfer improves outcome in patients with previous failed in vitro fertilization cycles | 31.7 | 0 | 2 |
| Increased endometrial thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Impact of Anticardiolipin Antibody on the Outcome of In Vitro Fertilization and Embryo Transfer | 31.7 | 0 | 2 |
| Evolution of a highly successful in vitro fertilization-embryo transfer program | 31.7 | 0 | 2 |
| Effects of the intensity of downregulation on outcome of in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Differences in steroidogenic acute regulatory protein expression from the luteinizing-granulosa cells of patients undergoing in vitro fertilization with embryo transfer: implications for cycle outcomes | 31.7 | 0 | 2 |
| Influence of EmbryoGlue on the implantation of embryo and pregnancy outcome in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in vitro fertilization and embryo transfer? | 31.7 | 0 | 2 |
| Matched controlled study to evaluate the effect of endometrial polyps on pregnancy and implantation rates following in vitro fertilization-embryo transfer (IVF-ET) | 31.7 | 0 | 2 |
| Successful pregnancy using known donor oocytes fertilized in vitro by spermatozoa obtained by electro-ejaculation from a quadriplegic husband | 31.7 | 0 | 2 |
| The relationship between endogenous oestradiol and vitamin D3 metabolites in serum and follicular fluid during ovarian stimulation for in-vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| The effect of smoking on infertility treatment in women undergoing assisted reproduction cycles | 31.7 | 0 | 2 |
| The cytology of vaginal, cervical and endometrial smears obtained at the time of embryo transfer during in vitro fertilization | 31.7 | 0 | 2 |
| The role of tubal pathology and other parameters in ectopic pregnancies occurring in in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Impact of ketorolac administration around ovarian stimulation onin vivoandin vitrofertilization and subsequent embryo development | 31.7 | 0 | 2 |
| Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis | 31.7 | 0 | 2 |
| Influence of severe endometriosis on gene expression of vascular endothelial growth factor and interleukin-6 in granulosa cells from patients undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Deletion of chromosome 4: 46,XY, del(4) (q31.3) after gamete intrafallopian transfer and in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| A model to show human uterine receptivity and embryo viability following ovarian stimulation for in vitro fertilization. | 31.7 | 0 | 2 |
| Comparison of singleton and multiple pregnancies in in vitro fertilization (IVF) and embryo transfer (ET). | 31.7 | 0 | 2 |
| Dummy embryo transfer: a technique that minimizes the problems of embryo transfer and improves the pregnancy rate in human in vitro fertilization | 31.7 | 0 | 2 |
| Delayed fertilization during in vitro fertilization and embryo transfer cycles: analysis of causes and impact on overall results. | 31.7 | 0 | 2 |
| Impact of high response of ovary to gonadotropin stimulation on the outcome of in vitro fertilization and embryo transfer or intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| In Vitro Fertilization of Preovulatory Oocytes and Embryo Transfer in Infertile Patients Treated with Clomiphene and Human Chorionic Gonadotropin | 31.7 | 0 | 2 |
| Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen | 31.7 | 0 | 2 |
| The effect of endometriosis on pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women with decreased egg reserve | 31.7 | 0 | 2 |
| Relationship of antisperm antibodies to oocyte fertilization in in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Pregnancy-specific beta 1-glycoprotein (SP1) after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment | 31.7 | 0 | 2 |
| The significance of the ionophore-challenged acrosome reaction in the prediction of successful outcome of controlled ovarian stimulation and intrauterine insemination | 31.7 | 0 | 2 |
| An ectopic pregnancy in the upper retroperitoneum following in vitro fertilization and embryo transfer. | 31.7 | 0 | 2 |
| Injection of day 2 embryo culture supernatant into the uterine cavity did not improve the pregnancy rate of day 3 embryo transfer in patients who underwent in vitro fertilization-embryo transfer: a randomized clinical trial | 31.7 | 0 | 2 |
| Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens | 31.7 | 0 | 2 |
| Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization–embryo transfer | 31.7 | 0 | 2 |
| Human oocyte cryopreservation as an adjunct to IVF-embryo transfer cycles | 31.7 | 0 | 2 |
| Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. | 31.7 | 0 | 2 |
| Monitoring of in vitro fertilization-embryo transfer cycles by ultrasound versus by ultrasound and hormonal levels: a prospective, multicenter, randomized study. | 31.7 | 0 | 2 |
| In vitro sperm capacitation and intrauterine insemination (IVC-Insem): a simple technique for the treatment of refractory infertility unrelated to female organic pelvic disease. Clinical results and immunological effects: a preliminary report | 31.7 | 0 | 2 |
| The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial | 31.7 | 0 | 2 |
| Significantly lower ectopic pregnancy rates after frozen embryo transfer: implications toward segmentation of in vitro fertilization treatment | 31.7 | 0 | 2 |
| Effect of low-dose triptorelin on pituitary down-regulation for patients undergoing in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Prognostic factors for successful outcome in patients undergoing controlled ovarian stimulation and intrauterine insemination | 31.7 | 0 | 2 |
| The results of a program of in vitro fertilization and tubal embryo transfer (ZIFT) | 31.7 | 0 | 2 |
| Ovarian cysts decrease the success of controlled ovarian stimulation and in vitro fertilization | 31.7 | 0 | 2 |
| Intratubal transfer of an embryo or a zygote. (TET or GIFT) Past, present and future? Comparative study of tubal embryo transfer (TET) versus in vitro fertilization | 31.7 | 0 | 2 |
| Cumulus Cell Mitochondrial Resistance to Stress In Vitro Predicts Oocyte Development During Assisted Reproduction | 31.7 | 0 | 2 |
| Bilateral ovarian maldescent: Unusual cause of infertility – A case report and literature review | 31.7 | 0 | 2 |
| Hypersensitivity to progesterone-in-oil after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Functioning of families with primary school-age children conceived using anonymous donor sperm. | 31.7 | 0 | 2 |
| Recombinant FSH vs. urinary FSH for ovarian stimulation in in vitro fertilization. | 31.7 | 0 | 2 |
| Donor insemination, adoption, in vitro fertilization: psychosocial and psychosexual aspects | 31.7 | 0 | 2 |
| LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. | 31.7 | 0 | 2 |
| Two cases of systemic Candida glabrata infection following in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Effect of ovarian stimulation on plasma lipid and apolipoprotein concentrations in a population of infertile women undergoing IVF/embryo transfer | 31.7 | 0 | 2 |
| In vitro fertilization: the degree of endometrial insufficiency varies with the type of ovarian stimulation | 31.7 | 0 | 2 |
| Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination | 31.7 | 0 | 2 |
| Treatment-independent, treatment-associated, and pregnancies after additional therapy in a program of in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Risk factors for ectopic pregnancy after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Successful pregnancy after in vitro fertilization and embryo transfer from an infertile woman to a surrogate | 31.7 | 0 | 2 |
| Factors influencing successful in vitro fertilization and embryo transfer: a matched pair study | 31.7 | 0 | 2 |
| The influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Twin pregnancy outcome among cases of spontaneous conception, intrauterine insemination, and in vitro fertilization/intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| Successful completion of pregnancy after fertilization in vitro and embryo transfer | 31.7 | 0 | 2 |
| Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients | 31.7 | 0 | 2 |
| Immunophenotypic profiles of peripheral blood lymphocytes on the day of embryo transfer in women undergoing in vitro fertilization | 31.7 | 0 | 2 |
| Maternal serum progesterone concentration and early conceptus development of bovine embryos produced in vivo or in vitro | 31.7 | 0 | 2 |
| Use of in vitro fertilization and embryo transfer to circumvent infertility caused by an inherited imperforate vagina in mice | 31.7 | 0 | 2 |
| Ultrasound guidance of embryo transfer: A role for midwife | 31.7 | 0 | 2 |
| Cumulative delivery rate in an in vitro fertilization program with a single embryo transfer policy | 31.7 | 0 | 2 |
| β-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients | 31.7 | 0 | 2 |
| Embryo transfer to the uterus or the fallopian tube after in vitro fertilization yields similar results | 31.7 | 0 | 2 |
| Endometrial thickness and growth during ovarian stimulation: a possible predictor of implantation in in vitro fertilization | 31.7 | 0 | 2 |
| Hepatitis B infection and outcomes of in vitro fertilization and embryo transfer treatment | 31.7 | 0 | 2 |
| Mock embryo transfer in early luteal phase, the cycle before in vitro fertilization and embryo transfer: a descriptive study | 31.7 | 0 | 2 |
| Ovarian stimulation for in vitro fertilization in low-responder patients using pulsatile intravenous follicle stimulating hormone | 31.7 | 0 | 2 |
| Is there any place for oocyte cryopreservation after cancer treatment? | 31.7 | 0 | 2 |
| Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization | 31.7 | 0 | 2 |
| The window of embryo transfer and the efficiency of human conception in vitro. | 31.7 | 0 | 2 |
| IVF with planned single-embryo transfer versus IUI with ovarian stimulation in couples with unexplained subfertility: an economic analysis | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer: an established and successful therapy for endometriosis | 31.7 | 0 | 2 |
| Gonadotropin stimulation for in vitro fertilization and embryo transfer in insulin-dependent diabetics: follicular response, oocyte quality, embryo development, and follicular environment | 31.7 | 0 | 2 |
| Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients | 31.7 | 0 | 2 |
| Correlative analysis of social support with anxiety and depression in men undergoing in vitro fertilization embryo transfer for the first time | 31.7 | 0 | 2 |
| Survival of the cornual pregnancy in a heterotopic gestation after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Suboptimal laboratory conditions can affect pregnancy outcome after embryo transfer on day 1 or 2 after insemination in vitro | 31.7 | 0 | 2 |
| Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study | 31.7 | 0 | 2 |
| Study on leuprorelin acetate in treatment of uterine adenomyosis with infertility | 31.7 | 0 | 2 |
| Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study | 31.7 | 0 | 2 |
| High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization | 31.7 | 0 | 2 |
| Serum beta human chorionic gonadotropin levels on day 12 after in vitro fertilization in predicting final type of clinical pregnancy | 31.7 | 0 | 2 |
| An assessment of alternative policies for embryo transfer in an in vitro fertilization-embryo transfer program | 31.7 | 0 | 2 |
| Effects of the severity of tubo-ovarian disease and previous tubal surgery on the results of in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Abdominal pregnancy after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Monitoring gonadotropin-stimulated cycles for in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis | 31.7 | 0 | 2 |
| Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| The efficiency of human reproduction after in vitro fertilization and embryo transfer. | 31.7 | 0 | 2 |
| Mechanisms and factors of early pregnancy wastage in in vitro fertilization-embryo transfer patients. | 31.7 | 0 | 2 |
| Low-dose glucocorticoids after in vitro fertilization and embryo transfer have no significant effect on pregnancy rate. | 31.7 | 0 | 2 |
| Serum progesterone and estradiol concentrations in the early diagnosis of ectopic pregnancy after in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Embryo transfer as a means of controlling the transmission of viral infections. IX. The in vitro exposure of zona pellucida-intact porcine embryos to swine vesicular disease virus | 31.7 | 0 | 2 |
| A higher anti-Müllerian hormone level is associated with an increased chance of pregnancy in patients undergoing controlled ovarian stimulation and intrauterine insemination | 31.7 | 0 | 2 |
| Impact of detection of bacterial endotoxin in menstrual effluent on the pregnancy rate in in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| A 10-year survey on birth defects after in vitro fertilization-embryo transfer in Shanghai | 31.7 | 0 | 2 |
| Risk-sharing or refund programs in assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility. | 31.7 | 0 | 2 |
| Reproductive medicine and the law: egg donation in Germany, Spain and other European countries | 31.7 | 0 | 2 |
| Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature? | 31.7 | 0 | 2 |
| The midluteal decline in serum estradiol levels is drastic but not deleterious for implantation after in vitro fertilization and embryo transfer in patients with normal or high responses | 31.7 | 0 | 2 |
| Preovulatory follicular fluid: relationships to ovarian stimulation protocol, fertilization, and sperm penetration in vitro | 31.7 | 0 | 2 |
| Isolation of seminal and vaginal bacteria from patients on a protocol of in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Intrauterine candidiasis in a twin pregnancy after myomectomy, in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial | 31.7 | 0 | 2 |
| Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial | 31.7 | 0 | 2 |
| Effect of halving the daily dose of triptorelin at the start of ovarian stimulation on hormone serum levels and the outcome of in vitro fertilization | 31.7 | 0 | 2 |
| Misdiagnosis and delayed diagnosis for ectopic and heterotopic pregnancies after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy | 31.7 | 0 | 2 |
| Comparison of the efficacy of treating sperm with low hypoosmotic swelling test scores with chymotrypsin followed by intrauterine insemination vs in vitro fertilization with intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| Can India save its Parsi community with assisted reproduction? | 31.7 | 0 | 2 |
| Embryo transfer as a means of controlling the transmission of viral infections. XI. The in vitro exposure of bovine and porcine embryos to vesicular stomatitis virus | 31.7 | 0 | 2 |
| Embryo transfer as a means of controlling the transmission of viral infections. VII. The in vitro exposure of bovine and porcine embryos to foot-and-mouth disease virus | 31.7 | 0 | 2 |
| Embryo transfer as a means of controlling the transmission of viral infections. II. The in vitro exposure of preimplantation bovine embryos to infectious bovine rhinotracheitis virus | 31.7 | 0 | 2 |
| Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET). | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization | 31.7 | 0 | 2 |
| Effects of early-cleavage embryo transfer on in vitro fertilization-embryo transfer pregnancy outcomes | 31.7 | 0 | 2 |
| Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile | 31.7 | 0 | 2 |
| In Vitro Fertilization and Embryo Transfer | 31.7 | 0 | 2 |
| Single curettage endometrial biopsy injury in the proliferative phase improves reproductive outcome of subsequent in vitro fertilization-embryo transfer cycle in infertile patients with repeated embryo implantation failure | 31.7 | 0 | 2 |
| Response to 'Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?'. | 31.7 | 0 | 2 |
| Parthenogenic activation of surplus in vitro-matured human oocytes: a tool for validation of oocyte cryopreservation | 31.7 | 0 | 2 |
| Early primary abdominal pregnancy after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Improving in vitro maturation and pregnancy outcome in cattle using a novel oocyte shipping and maturation system not requiring a CO2 gas phase | 31.7 | 0 | 2 |
| Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| A program for in vitro fertilization and embryo transfer at the Southern California Fertility Institute, Inc. | 31.7 | 0 | 2 |
| Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients. | 31.7 | 0 | 2 |
| Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome | 31.7 | 0 | 2 |
| Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic g | 31.7 | 0 | 2 |
| Public policy aspects of assisted reproduction. Vth World Congress, IVF and embryo transfer | 31.7 | 0 | 2 |
| Infertility Stress in Couples Undergoing Intrauterine Insemination and In Vitro Fertilization Treatments. | 31.7 | 0 | 2 |
| Live birth of a normal mature healthy baby by in vitro fertilization-embryo transfer (IVF-ET) after an exploratory laparotomy and multiple myomectomy for leiomyomatosis peritonealis disseminata | 31.7 | 0 | 2 |
| Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization | 31.7 | 0 | 2 |
| Effect of polychlorinated biphenyls (PCBs) and 1,1,1-trichloro-2,2,-bis (4-chlorophenyl)-ethane (DDT) in follicular fluid on the results of in vitro fertilization-embryo transfer (IVF-ET) programs. | 31.7 | 0 | 2 |
| Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Sonohysterography as a first-line evaluation for uterine abnormalities in women with recurrent failed in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Generating Transgenic Mice by Lentiviral Transduction of Spermatozoa Followed by In Vitro Fertilization and Embryo Transfer | 31.7 | 0 | 2 |
| Evaluation for the clinical application of all embryos cryopreservation: a multi-centre study in northern area of China | 31.7 | 0 | 2 |
| Legislative guidelines to govern in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Changes in serum cortisol and prolactin associated with acupuncture during controlled ovarian hyperstimulation in women undergoing in vitro fertilization-embryo transfer treatment | 31.7 | 0 | 2 |
| Impact of antiovarian antibodies (AOA) on ovarian responsiveness in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Is letrozole superior to clomiphene for ovarian stimulation prior to intrauterine insemination? | 31.7 | 0 | 2 |
| Casting for determinants of blastocyst yield and of rates of implantation and of pregnancy after blastocyst transfers | 31.7 | 0 | 2 |
| Submicroscopic mathematical evaluation of spermatozoa in assisted reproduction. 2. In vitro fertilization (notulae seminologicae. 7). | 31.7 | 0 | 2 |
| Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer | 31.7 | 0 | 2 |
| Need for Comprehensive Counseling in Women Requesting Oocyte Cryopreservation | 31.7 | 0 | 2 |
| The effect of medical clowning on pregnancy rates after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Rosacea fulminans in the early course of a pregnancy by in vitro fertilization with embryo transfer | 31.7 | 0 | 2 |
| Intrauterine insemination of cultured peripheral blood mononuclear cells prior to embryo transfer improves clinical outcome for patients with repeated implantation failures | 31.7 | 0 | 2 |
| Principles of medical ethics in the in vitro fertilization and embryo transfer program | 31.7 | 0 | 2 |
| The effect of ovarian stimulation on the outcome of intrauterine insemination | 31.7 | 0 | 2 |
| Simultaneous bilateral tubal pregnancy after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Neonatal outcomes of pregnancy resulting from in vitro fertilization and embryo transfer: analysis of 1274 cases | 31.7 | 0 | 2 |
| Analysis of pregnancy outcomes after in vitro fertilization-embryo transfer and intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| Slightly lower incidence of ectopic pregnancies in frozen embryo transfer cycles versus fresh in vitro fertilization-embryo transfer cycles: a retrospective cohort study | 31.7 | 0 | 2 |
| Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| In vitro fertilization through egg donation: a prospective view of legal issues. | 31.7 | 0 | 2 |
| In Vitro Fertilisation and Embryo Transfer. | 31.7 | 0 | 2 |
| Bilateral tubal pregnancy following in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Simultaneous bilateral tubal pregnancies after in vitro fertilization and embryo transfer: report of a case | 31.7 | 0 | 2 |
| Leuprolide acetate reduces both in vivo and in vitro ovarian steroidogenesis in infertile women undergoing assisted reproduction. | 31.7 | 0 | 2 |
| Heterotopic pregnancy after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Ovarian stimulation for fertility preservation in patients with cancer | 31.7 | 0 | 2 |
| Estrogen role in the luteal phase support in in vitro fertilization with embryo transfer cycles | 31.7 | 0 | 2 |
| Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation | 31.7 | 0 | 2 |
| The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium. | 31.7 | 0 | 2 |
| Effective method for emergency fertility preservation: random-start controlled ovarian stimulation | 31.7 | 0 | 2 |
| Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles | 31.7 | 0 | 2 |
| Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin | 31.7 | 0 | 2 |
| Intrauterine insemination with controlled ovarian stimulation for treatment of infertility: an audit of a new IUI programme in a low resource setting | 31.7 | 0 | 2 |
| The first reported case of Down syndrome in the Southern California Fertility Institute's in vitro fertilization and embryo transfer program | 31.7 | 0 | 2 |
| Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormo | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer: Northridge Hospital Medical Center, California | 31.7 | 0 | 2 |
| Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine inseminatio | 31.7 | 0 | 2 |
| Association of leptin with poor ovarian stimulation during in vitro fertilization. | 31.7 | 0 | 2 |
| Posthumous assisted reproduction: a survey of attitudes of couples seeking fertility treatment and the degree of agreement between intimate partners | 31.7 | 0 | 2 |
| Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study | 31.7 | 0 | 2 |
| Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria. | 31.7 | 0 | 2 |
| Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program | 31.7 | 0 | 2 |
| Results of prednisolone given to improve the outcome of in vitro fertilization-embryo transfer in women with antinuclear antibodies | 31.7 | 0 | 2 |
| AB077. Relationship of TPO-Ab and TSH with in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial | 31.7 | 0 | 2 |
| Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy | 31.7 | 0 | 2 |
| Two successful pregnancies after in vitro fertilization and embryo transfer in a patient with endometrial atypical hyperplasia bordering on adenocarcinoma treated conservatively with high-dose progesterone | 31.7 | 0 | 2 |
| Validation of Correction Factors for Serum Markers for First-Trimester Down Syndrome Screening in Singleton Pregnancies Conceived with Assisted Reproduction | 31.7 | 0 | 2 |
| Factors associated with dizygotic twinning after IVF treatment with double embryo transfer | 31.7 | 0 | 2 |
| An in vitro fertilization and embryo transfer pilot study: treatment-dependent and treatment-independent pregnancies | 31.7 | 0 | 2 |
| Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study | 31.7 | 0 | 2 |
| Effect of ultrasound-guided aspiration of hydrosalpingeal fluid during oocyte retrieval on the outcomes of in vitro fertilisation-embryo transfer: a randomised controlled trial (NCT01040351). | 31.7 | 0 | 2 |
| Impact of the mandatory age-based single-embryo transfer legislation in Turkey on outcome of in vitro fertilization: a multicentre study | 31.7 | 0 | 2 |
| Unilateral oophorectomy results in compensatory follicular recruitment in the remaining ovary at time of ovarian stimulation for in vitro fertilization | 31.7 | 0 | 2 |
| The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination | 31.7 | 0 | 2 |
| Effect of pelvic inflammatory disease grades on in vitro fertilization-embryo transfer outcome | 31.7 | 0 | 2 |
| The variation of serum cortisol during ovarian stimulation for in vitro fertilization | 31.7 | 0 | 2 |
| Pregnancy outcomes in a university hospital after legal requirement for single-embryo transfer | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer in Pretoria | 31.7 | 0 | 2 |
| Fertility preservation with ovarian stimulation protocols prior to cancer treatment | 31.7 | 0 | 2 |
| Selection of nonapoptotic spermatozoa as a new tool for enhancing assisted reproduction outcomes: an in vitro model | 31.7 | 0 | 2 |
| The use of time lapse photography in an in vitro fertilization programme for better selection for embryo transfer. | 31.7 | 0 | 2 |
| Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination | 31.7 | 0 | 2 |
| How do we decide how many embryos are safe for transfer? | 31.7 | 0 | 2 |
| An efficient method of ovarian stimulation and in vitro embryo production from prepubertal lambs | 31.7 | 0 | 2 |
| Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial | 31.7 | 0 | 2 |
| Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 31.7 | 0 | 2 |
| In vitro fertilization and embryo transfer in a Deaconess Institution. Experience from the first years | 31.7 | 0 | 2 |
| Three successful pregnancies with in vitro fertilization embryo transfer over an eight year time span despite elevated basal serum follicle stimulating hormone levels. Case report | 31.7 | 0 | 2 |
| Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization-embryo transfer: patient preference and drug efficacy | 31.7 | 0 | 2 |
| Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion | 31.7 | 0 | 2 |
| Clinical results of Stanford University's in vitro fertilization and embryo transfer program | 31.7 | 0 | 2 |
| A controlled study between the use of gamete intrafallopian transfer (GIFT) and in vitro fertilization and embryo transfer in the management of idiopathic and male infertility | 31.7 | 0 | 2 |
| Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles | 31.7 | 0 | 2 |
| Fertility outcomes in infertile women with complex hyperplasia or complex atypical hyperplasia who received progestin therapy and in vitro fertilization | 31.7 | 0 | 2 |
| In vitro maturation of human immature oocytes for fertility preservation and research material | 31.7 | 0 | 2 |
| Mesenteric vein thrombosis following impregnation via in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| The SUPER study: protocol for a randomised controlled trial comparing follicle-stimulating hormone and clomiphene citrate for ovarian stimulation in intrauterine insemination | 31.7 | 0 | 2 |